Apple Wins ITC Case, Averting New Watch Import Ban

ITC Upholds Ruling in Apple's Favor

The U.S. International Trade Commission (ITC) has finalized a decision in favor of Apple, rejecting medtech company Masimo's attempt to reinstate an import ban on the Apple Watch Series 9 and Ultra 2 models. The ruling affirms a judge's preliminary finding from March that the redesigned watches do not infringe on Masimo's patents.

Overview of the Patent Dispute

The dispute centers on patents for blood-oxygen reading technology. The ITC had previously banned the watches in December 2023, leading Apple to redesign the feature. The updated watches alter how health data is accessed and displayed to avoid infringement, a change approved by U.S. Customs and Border Protection, allowing sales to resume.

Market Implications

This decision is a significant victory for Apple, ensuring it can continue selling its latest smartwatches in the U.S. market without interruption. For Masimo, the legal battle is not over, as the company can appeal the ITC's decision to the U.S. Court of Appeals and has other ongoing lawsuits against Apple concerning patent infringement and trade-secret theft.

Summary and Outlook

While Apple has secured a key win at the trade tribunal, the broader legal conflict with Masimo persists. The market will continue to monitor the ongoing litigation, including any potential appeals from Masimo, which could introduce further uncertainty for both companies.

FAQ

Q: Why was there an import ban on the Apple Watch?
A: The ITC initially found that Apple's watches infringed on Masimo's patents for blood-oxygen sensor technology, leading to a temporary import ban in late 2023.

Q: Does this ruling end the legal battle between Apple and Masimo?
A: No, this decision only closes this specific ITC case. Masimo can appeal and has other active lawsuits against Apple in federal court.

Source: Investing.com